A New Modulator of Neuroinflammation in Diabetic Retinopathy: USP25
In conclusion, the promotion of diabetic retinopathy (DR) progression by USP25 is attributed to its facilitation of microglial activation induced by high glucose levels, a process med iated by the ROCK pathway. These findings highlight the importance of considering USP25 as a potential therapeutic target for the management of diabetic neuroinflammation.
Source: Inflammation - Category: Allergy & Immunology Source Type: research
More News: Allergy & Immunology | Brain | Diabetes | Endocrinology | Environmental Health | Neurology | Study | Translocation | Vitamin A